Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

NIOSH Testimony on Recombinant DNA by Dr. J. F. Finklea, March 16, 1977.

NIOSH 1977 Mar:10 pages
This testimony described the function of NIOSH. The purpose of the statement was to discuss the involvement of NIOSH and the Center for Disease Control (CDC) in the subject of recombinant DNA research. The involvement of NIOSH with the Federal Government in their attempts to make recommendations dealing with the regulation of recombinant DNA research was discussed and some suggestions were offered on the safeguards felt necessary for the protection of the worker. Meetings have been held with interested parties to discuss this issue wherein the technical aspects of recombinant DNA research were considered and how the existing regulations might affect these activities. At this time there existed no way in which the workers at public universities were protected while conducting research funded by industry. Nine issues were identified as early as November of 1976 for consideration in the development of health and safety issues: establishment of a central registry of all workers engaged in such research, provide appropriate medical examinations, train all workers and inform them of the hazards, adequately label and post precautions, provision to retain all health records for 30 years, make mandatory the reporting of all illness and other like happenings, install appropriate monitoring systems, provide adequate health insurance coverage for the workers, and make certain that workers' compensation provisions are adequate. Currently there is no uniformity of opinion on how occupational safety and health issues should be resolved.
NIOSH-Author; NIOSH-Testimony; Finklea-J-F; Occupational-safety-programs; Nucleic-acids; Medical-research; Worker-health; Work-practices; Infectious-diseases; Biohazards;
Publication Date
Fiscal Year
NTIS Accession No.
NTIS Price
Priority Area
Infectious Diseases; Disease and Injury;
Source Name
NIOSH, 10 pages